Sensitivity versus specificity in melanoma imaging using iodine-123 iodobenzamide and indium-111 pentetreotide [1].
Maffioli
L
L
Chiti
A
A
Gasparini
M
M
Bombardieri
E
E
D001549:Benzamides; D003287:Contrast Media; D018492:Dopamine Antagonists; D006801:Humans; D007205:Indium Radioisotopes; D007457:Iodine Radioisotopes; D008545:Melanoma / Q000000981:diagnostic imaging*; D011759:Pyrrolidines; D016719:Radioimmunodetection; D012680:Sensitivity and Specificity; D012878:Skin Neoplasms / Q000000981:diagnostic imaging*; D013004:Somatostatin / Q000031:analogs & derivatives*
D001549:Benzamides; D003287:Contrast Media; D018492:Dopamine Antagonists; D007205:Indium Radioisotopes; D007457:Iodine Radioisotopes; D011759:Pyrrolidines; D013004:Somatostatin; C055743:3-iodo-2-hydroxy-6-methoxy-N-((1-ethyl-2-pyrrolidinyl)methyl)benzamide; C081788:pentetreotide